OTHER GROUP COMPANIES
market

Glenmark Pharmaceuticals Aurangabad unit undergoes USFDA inspection

Glenmark Pharmaceuticals Aurangabad unit undergoes USFDA inspection

July 02, 2022 12:34 IST | capital market
Glenmark Pharmaceuticals announced that the USFDA has issued Form 483 with one observation after an inspection at the Companys formulation manufacturing facility based out of Aurangabad, India between 27 June 2022 and 01 July 2022. Powered by Capital Market - Live News

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000

FEATURED ARTICLE

BLOGS

Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity